methoctramine has been researched along with carbamates in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brefel-Courbon, C; Freslon, JL; Lazartigues, E; Montastruc, JL; Pelat, M; Rascol, O; Tellioglu, T; Tran, MA | 1 |
Boehm, S; Drobny, H; Kosenburger, K; Kubista, H; Mahlknecht, P | 1 |
Amari, G; Bassani, F; Battipaglia, L; Bergamaschi, M; Berti, F; Bolzoni, PT; Cacciani, F; Cenacchi, V; Civelli, M; Delcanale, M; Geppetti, PA; Harrison, S; Mannini, F; Pastore, F; Patacchini, R; Petrillo, P; Razzetti, R; Rizzi, A; Rossoni, G; Santoro, E; Scudellaro, R; Villetti, G; Volta, R; Zaniboni, M | 1 |
3 other study(ies) available for methoctramine and carbamates
Article | Year |
---|---|
Pressor and bradycardic effects of tacrine and other acetylcholinesterase inhibitors in the rat.
Topics: Adrenergic Antagonists; Animals; Antidiuretic Hormone Receptor Antagonists; Atropine; Atropine Derivatives; Blood Pressure; Carbamates; Cardiovascular Agents; Chlorisondamine; Cholinergic Antagonists; Cholinesterase Inhibitors; Diamines; Diastole; Dose-Response Relationship, Drug; Heart Rate; Male; Phenylcarbamates; Physostigmine; Piperidines; Pirenzepine; Rats; Rats, Wistar; Rivastigmine; Systole; Tacrine | 1998 |
Inhibition of transmitter release from rat sympathetic neurons via presynaptic M(1) muscarinic acetylcholine receptors.
Topics: Acetylcholine; Action Potentials; Adrenergic Fibers; Animals; Animals, Newborn; Calcium Channel Blockers; Calcium Channels; Calcium Signaling; Carbamates; Cells, Cultured; Diamines; Dose-Response Relationship, Drug; Electric Stimulation; KCNQ Potassium Channels; Muscarinic Agonists; Muscarinic Antagonists; Neural Inhibition; Norepinephrine; omega-Conotoxin GVIA; Oxotremorine; Pertussis Toxin; Phenylenediamines; Pirenzepine; Presynaptic Terminals; Rats; Rats, Sprague-Dawley; Receptor, Muscarinic M1; Receptors, Presynaptic; Superior Cervical Ganglion; Synaptic Transmission; Time Factors; Type C Phospholipases | 2009 |
Bronchodilator activity of (3R)-3-[[[(3-fluorophenyl)[(3,4,5-trifluorophenyl)methyl]amino] carbonyl]oxy]-1-[2-oxo-2-(2-thienyl)ethyl]-1-azoniabicyclo[2.2.2]octane bromide (CHF5407), a potent, long-acting, and selective muscarinic M3 receptor antagonist.
Topics: Acetylcholine; Aged; Anesthesia; Animals; Blood Pressure; Bronchi; Bronchial Spasm; Bronchoconstriction; Bronchoconstrictor Agents; Bronchodilator Agents; Carbachol; Carbamates; CHO Cells; Cricetinae; Cricetulus; Diamines; Guinea Pigs; Heart Atria; Heart Rate; Humans; Kinetics; Male; Middle Aged; Molecular Structure; Muscarinic Antagonists; Myocardial Contraction; Quinuclidines; Receptor, Muscarinic M1; Receptor, Muscarinic M2; Receptor, Muscarinic M3; Scopolamine Derivatives; Tiotropium Bromide; Trachea; Transfection; Ventricular Function, Left | 2010 |